Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants

Blood

Volumn 101, Issue 4, 2003, Pages 1570-1571

  Avet Loiseau, Hervé ^a,b   Garand, Richard ^a   Lodé, Laurence ^a   Harousseau, Jean Luc ^a   Bataille, Régis ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENCE JONES PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M;

ARTICLE; CHROMOSOME 13Q; CHROMOSOME 14; CHROMOSOME TRANSLOCATION 11; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0037441892     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-08-2436     Document Type: Article

References (13)

1. MacLennan ICM. In which cells does neoplastic transformation occur in myelomatosis? Curr Top Microbiol Immunol. 1992;182:209-213.
2. Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features and clinical presentation. Blood. 2002;99:2185-2191.
3. Juge-Morineau N, Heirman C, Bakkus M, et al. Immunoglobulins D and M multiple myeloma variants are heavily mutated. Clin Cancer Res. 1997;3:2501-2506.
4. Sahota SS, Garand R, Mahroof R, et al. V(H) gene analysis of IgM-secreting myeloma indicates an origin from a memory cell undergoing isotype switch events. Blood. 1999;94:1070-1076.
5. Sahota SS, Garand R, Bataille R, Smith AJ, Stevenson FK. VH gene analysis of clonally related IgM and IgG from human lymphoplasmacytold B-cell tumors with chronic lymphocytic leukemia features and high serum monoclonal IgG. Blood. 1998;91:238-243.
6. Garand R, Sahota SS, Avet-Loiseau H, et al. IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated VH genes undergoing Ig isotype-switching frequently associated with trisomy 12. Br J Haematol. 2000;109:71-80.
7. Gabrea A, Bergsagel PL, Chesi M, Shou Y, Kuehl WM. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell. Mol Cell. 1999;3:119-123.
8. Fonseca R, Blood EA, Oken MM, et al. Myeloma and the t(11;14)(q13;q32): evidence for a biologically defined unique subset of patients. Blood. 2002;99:3735-3341.
9. Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W. Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases. Am J Clin Pathol. 1987;87:342-355.
10. Preud'Homme JL, Hurez D, Danon F, Brouet JC, Seligmann M. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma. Clin Exp Immunol. 1976;25:428-436.
11. Hayman SR, Bailey RJ, Jalal SM, et al. Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis. Blood. 2001;98:2266-2268.
12. Moreau P, Facon T, Leleu X, et al. Recurrent 14q32 translocations determine the prognosis of multiple myeloma especially in patients receiving intensive chemotherapy. Blood. 2002;100:1579-1583.
13. Dreicer R, Alexanian R. Nonsecretory multiple myeloma. Am J Hematol. 1982;13:313-318.